Related Experiment Video

Updated: Aug 3, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA

S J Decker1

  • 1Parke-Davis Pharmaceuticals, Ann Arbor, Michigan 48106, USA.

The Journal of Biological Chemistry
|December 29, 1995
PubMed

Insights

Nerve growth factor (NGF) halts NIH-3T3 cell division by increasing p21Cip1/WAF1 protein levels, leading to cell cycle arrest. This demonstrates distinct signaling pathways for TrkA and EGF receptors.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Nerve growth factor (NGF) is crucial for neuronal development and survival.
  • Understanding NGF's role in cell cycle regulation provides insights into cellular processes.

Purpose of the Study:

  • To investigate the effects of NGF on NIH-3T3 cell proliferation.
  • To elucidate the molecular mechanisms underlying NGF-induced cell cycle arrest.
  • To compare signaling pathways activated by TrkA and EGF receptors.

Main Methods:

  • Treatment of NIH-3T3 cells with NGF and EGF.
  • Cell cycle analysis using flow cytometry.
  • Western blotting to assess protein levels (p21Cip1/WAF1, p27KIP1, p16INK4, CDK2, CDK4, Cyclin E, Cyclin D).
  • Kinase activity assays for CDK2 and CDK4.

Main Results:

  • NGF treatment caused G1 cell cycle arrest in NIH-3T3 cells.
  • NGF significantly increased p21Cip1/WAF1 protein levels, inhibiting CDK2 and CDK4 activity.
  • EGFR signaling had minimal impact on p21Cip1/WAF1 expression.
  • NGF led to decreased CDK2/CDK4 levels but increased Cyclin E/Cyclin D levels.

Conclusions:

  • NGF induces cell cycle arrest in NIH-3T3 cells, likely via p21Cip1/WAF1 modulation.
  • TrkA and EGF receptors generate distinct intracellular signals.
  • NGF's effect on cell cycle regulators highlights its complex role beyond neuronal function.

More Related Videos

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...